Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide
The IL-13Rα2 cell surface receptor is highly expressed in tumours such as prostate cancer. In this report, we evaluated the hypothesis that prostate cancer cells with enhanced IL-13Rα2 expression are a suitable target for the hybrid lytic peptide (Pep-1-Phor21) peptide, which is generated by fusing...
Main Authors: | Riaz Jannoo, Zhidao Xia, Paula E. Row, Venkateswarlu Kanamarlapudi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/2/356 |
Similar Items
-
Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide
by: Riaz Jannoo, et al.
Published: (2023-05-01) -
iIL13Pred: improved prediction of IL-13 inducing peptides using popular machine learning classifiers
by: Pooja Arora, et al.
Published: (2023-04-01) -
The Essentials on microRNA-Encoded Peptides from Plants to Animals
by: Mélanie Ormancey, et al.
Published: (2023-01-01) -
Multi-Layered PLGA-PEI Nanoparticles Functionalized with TKD Peptide for Targeted Delivery of Pep5 to Breast Tumor Cells and Spheroids
by: Mohan AK, et al.
Published: (2022-11-01) -
Synthetic Peptides against Plant Pathogenic Bacteria
by: Esther Badosa, et al.
Published: (2022-09-01)